Novel Turmeric Derivative Drug Shows Promise in Head and Neck Cancer
MONTREAL – An investigational drug derived from turmeric (Curcuma longa) appeared to have activity in patients being evaluated for head and neck cancer therapy, at least in an early phase trial. All nine oropharyngeal squamous cell carcinoma patients treated in the phase II trial had their disease under control after 4 to 6 weeks of […]